ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P ASX 200
7,015.20
(
0.39%
)
S&P ASX All Technology
2,427.20
(
-0.14%
)
Brent Oil
81.785
(
2.18%
)
US Dollar vs AUD
1.50292
(
-0.62%
)
Bitcoin
37,812.09
(
1.50%
)
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) News

XERS Xeris Biopharma Holdings Inc

1.7865
-0.0535 (-2.91%)
Last Updated: 03:33:37
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xeris Biopharma Holdings Inc XERS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0535 -2.91% 1.7865 03:33:37
Open Price Low Price High Price Close Price Previous Close
1.81 1.7646 1.83 1.84
more quote information »

Recent News

Date Time Source Heading
22/11/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:20EDGAR2Form 8-K - Current report
09/11/202323:00BWXeris Biopharma Reports Third Quarter 2023 Financial Results
16/10/202322:12EDGAR2Form 8-K - Current report
16/10/202322:00BWXeris Biopharma Raises Full-Year Financial Guidance and..
30/9/202306:55EDGAR2Form 8-K - Current report
27/9/202322:11EDGAR2Form 8-K - Current report
27/9/202322:00BWXeris Biopharma Announces Private Convertible Note Exchange..
15/9/202306:05BWXeris to Participate in the 2023 Cantor Global Healthcare..
28/8/202321:00BWXeris to Participate at the H.C. Wainwright 25th Annual..
09/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202321:23EDGAR2Form 8-K - Current report
08/8/202321:00BWXeris Biopharma Reports Second Quarter 2023 Financial..
01/8/202321:00BWXeris Biopharma to Report Second Quarter 2023 Financial..
31/7/202321:00BWXeris Ships One Millionth Gvoke® Unit
29/6/202306:28EDGAR2Form 8-K - Current report
21/6/202321:00BWXeris Biopharma Announces First Participant Dosed in a Phase..
01/6/202321:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
09/5/202321:00BWXeris Biopharma Reports First Quarter 2023 Financial Results
02/5/202321:00BWXeris Biopharma to Report First Quarter 2023 Financial..
18/4/202321:00BWXeris Biopharma Announces Issuance of U.S. Patent Covering..
30/3/202322:00BWXeris Biopharma Announces Research Evaluation Collaboration..
30/3/202307:05BWXeris Biopharma Appoints Ricki Fairley to Board of Directors
08/3/202322:00BWXeris Biopharma Reports Fourth Quarter and Full-Year 2022..
23/2/202323:00BWXeris Biopharma to Report Fourth Quarter and Full-Year 2022..
02/2/202323:00BWXeris Biopharma to Participate in the SVB Securities Global..
30/1/202323:58DJNXeris Biopharma Gets Orphan-Drug Exclusivity for Recorlev
30/1/202323:00BWXeris Biopharma Announces FDA Grants Orphan-drug Exclusivity..
06/1/202308:03BWXeris Biopharma to Present at 41st Annual J.P. Morgan..
05/1/202323:00BWXeris Biopharma Updates Its Outlook For 2022
15/12/202223:00BWXeris Biopharma Announces Plans for a Phase II Dose-Finding..

Your Recent History

NASDAQ
XERS
Xeris Biopharma

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com